103 related articles for article (PubMed ID: 2128598)
1. Effect of cisplatin and other biological response modifiers on the activity of lysozyme, plasminogen activator and 5' nucleotidase by murine macrophages in vitro.
Geetha B; Sodhi A
Biochem Int; 1990 Dec; 22(6):1103-14. PubMed ID: 2128598
[TBL] [Abstract][Full Text] [Related]
2. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. I. Macrophage-mediated tumor cell lysis.
Geetha B; Sodhi A
Nat Immun Cell Growth Regul; 1989; 8(2):100-7. PubMed ID: 2503714
[TBL] [Abstract][Full Text] [Related]
3. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. II. Production of H2O2, O2- and interleukin-1.
Sodhi A; Geetha B
Nat Immun Cell Growth Regul; 1989; 8(2):108-16. PubMed ID: 2548090
[TBL] [Abstract][Full Text] [Related]
4. Studies on the release of interleukin-1 (IL-1), tumor necrosis factor (TNF) and lysozyme from human non-adherent mononuclear cells (nMNC) in vitro after treatment with cisplatin and other biological response modifiers.
Sodhi A; Pai K
Neoplasma; 1992; 39(4):211-7. PubMed ID: 1436230
[TBL] [Abstract][Full Text] [Related]
5. Effect of cisplatin, rIFN-Y, LPS and MDP on release of H2O2, O2- and lysozyme from human monocytes in vitro.
Pai K; Sodhi A
Indian J Exp Biol; 1991 Oct; 29(10):910-5. PubMed ID: 1667647
[TBL] [Abstract][Full Text] [Related]
6. Effect of cisplatin on release of lysozyme, plasminogen activator, leucine aminopeptidase and beta-hexosaminidase by murine peritoneal macrophages in vitro.
Gupta P; Sodhi A
Indian J Exp Biol; 1988 Sep; 26(9):679-84. PubMed ID: 2977380
[No Abstract] [Full Text] [Related]
7. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
8. Studies on chemiluminescence and protein kinase-C activity of cisplatin treated mouse peritoneal exudate cells.
Geetha B; Sodhi A; Singh SM
Immunopharmacol Immunotoxicol; 1991; 13(1-2):1-10. PubMed ID: 1770212
[TBL] [Abstract][Full Text] [Related]
9. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
Saiki I; Fidler IJ
J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
[TBL] [Abstract][Full Text] [Related]
11. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
Nagao S; Sato K; Osada Y
Jpn J Cancer Res; 1987 Jan; 78(1):80-6. PubMed ID: 3102442
[TBL] [Abstract][Full Text] [Related]
12. Lipid A-associated proteins provide an alternate "second signal" in the activation of recombinant interferon-gamma-primed, C3H/HeJ macrophages to a fully tumoricidal state.
Hogan MM; Vogel SN
J Immunol; 1987 Dec; 139(11):3697-702. PubMed ID: 3119714
[TBL] [Abstract][Full Text] [Related]
13. [Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide].
Umanskiĭ VIu; Stefanov AV; Los' GV; Andronova TM; Balitskiĭ KP
Dokl Akad Nauk SSSR; 1986; 286(2):474-6. PubMed ID: 3004870
[No Abstract] [Full Text] [Related]
14. The response of isolated rabbit hepatic macrophages (H-M macrophage) to lipopolysaccharide (LPS).
Maier RV; Ulevitch RJ
Circ Shock; 1981; 8(2):165-81. PubMed ID: 7194747
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of Fc receptor expression in guinea pig peritoneal exudate macrophages by muramyl dipeptide or lipopolysaccharide.
Yagawa K; Kaku M; Ichinose Y; Nagao S; Tanaka A; Aida Y; Tomoda A
J Immunol; 1985 Jun; 134(6):3705-11. PubMed ID: 2985692
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of macrophage tumoricidal activity by glucocorticoids.
Hogan MM; Vogel SN
J Immunol; 1988 Jan; 140(2):513-9. PubMed ID: 3121748
[TBL] [Abstract][Full Text] [Related]
17. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
Le Contel C; Temime N; Charron DJ; Parant MA
J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
[TBL] [Abstract][Full Text] [Related]
18. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
Nagao S; Sato K; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):999-1002. PubMed ID: 3142490
[TBL] [Abstract][Full Text] [Related]
19. Synergistic induction of cytotoxicity in macrophages by murine interferon-gamma and biological response modifiers derived from microorganisms.
Nagao S; Sato K; Osada Y
Cancer Immunol Immunother; 1986; 23(1):41-5. PubMed ID: 3094943
[TBL] [Abstract][Full Text] [Related]
20. [The effect of muramyl dipeptide analog, GMPD, incorporated into liposomes of various composition on the functional activity of macrophages].
Stefanov AV; Bondar' OP; Umanskiĭ VIu; Lishko VK; Baletskiĭ KP
Ukr Biokhim Zh (1978); 1989; 61(6):63-9. PubMed ID: 2561033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
